Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
MIM Software Partners with Stanford to Deliver Telehealth to Ukrainians
MIM Software, a leading global medical imaging software provider, launches new TeleHelp Ukraine support to […]
Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focused on Clinical Oncology
Flamingo Therapeutics and Dynacure announced today that the companies have signed a definitive merger agreement to […]
Aptar Appoints Julie Xing to its Board of Directors
Aptar Group, a global leader in drug delivery, consumer product dispensing and active material science […]
Debiopharm Extends Their DNA Damage Repair Footprint With New Oncology Pipeline Entry
Debiopharm, an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer […]
Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]
Matinas BioPharma Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID
Matinas BioPharma, a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal […]
Lipella Pharmaceuticals Announces Creation of Oral Health Scientific Advisory Board
Lipella Pharmaceuticals, a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has announced […]
Tachyon Announces Financing and Start of Clinical Study of First-in-Class KDM4 Inhibitor for Advanced Cancers
Tachyon Therapeutics, a private, clinical-stage biotechnology company developing transformative cancer therapies against novel targets today […]
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
Vivalink’s Biometrics Data Platform Supports UCSF Clinical Trial for Hypertrophic Cardiomyopathy (HCM)
UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more